Management of Elevated Intracranial Pressure

Clinical Significance and Diagnosis

The Infectious Diseases Society of America (IDSA) defines an opening pressure ≥25 cm H₂O as elevated and requiring intervention, particularly when accompanied by symptoms of increased intracranial pressure 1
Normal opening pressure on lumbar puncture is generally considered to be <20-25 cm H₂O, making 34 mmHg (46 cm H₂O) significantly elevated 1
Extremely high opening pressures (>40 cm H₂O) indicate severe intracranial hypertension requiring aggressive management, and 34 mmHg approaches this threshold 1

Infectious etiologies, such as cryptococcal meningitis, bacterial meningitis, and other CNS infections, can cause significantly elevated opening pressure 2, 3, 4
Idiopathic intracranial hypertension (IIH), especially in patients with higher BMI, is a common cause of elevated opening pressure 1
Space-occupying lesions, such as tumors, abscesses, and hematomas, can also cause elevated opening pressure 5

For opening pressure ≥25 cm H₂O with symptoms, the Infectious Diseases Society of America (IDSA) recommends performing CSF drainage to reduce opening pressure by 50% or to achieve a closing pressure of <20 cm H₂O 3, 1
The American Academy of Neurology recommends removing enough CSF to reduce the pressure to approximately 17 mmHg (23 cm H₂O) 3, 4
Documenting the closing pressure after drainage is crucial for monitoring response to treatment 3

Visual disturbances, including loss of visual acuity, are a common manifestation of elevated intracranial pressure 3
Hearing loss is also a potential manifestation of elevated intracranial pressure 3
Pathological reflexes and altered mental status are additional clinical findings that may indicate elevated intracranial pressure 3

Brain imaging (CT or MRI) should be performed before lumbar puncture in patients with focal neurological signs or altered mental status to rule out mass lesions that could increase the risk of cerebral herniation 7, 1
Medical approaches, including corticosteroids, acetazolamide, or mannitol, have not shown clear benefit for managing elevated intracranial pressure in infectious conditions like cryptococcal meningitis 7, 1
Elevated intracranial pressure is a major contributor to morbidity and mortality in patients with cryptococcal meningitis, with 93% of deaths within the first 2 weeks of therapy and 40% of deaths within weeks 3-10 associated with increased intracranial pressure 6

Follow-up lumbar punctures should be performed if new symptoms or clinical findings occur after initial management 6
Serial measurement of CSF opening pressure is more useful than serum biomarkers for monitoring response in conditions like cryptococcal meningitis 6